Novartis | NVS - Ação





Ação Alterar Data
AbbVie USD 5.05B 98M 2026-03
Amgen USD 6.19B 39M 2026-03
AstraZeneca USD 6.57B 13M 2026-03
Bausch Health Companies USD 1.63B 31M 2025-12
Biogen USD 1.95B 219.1M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Canopy Growth CAD 110.51M 4.96M 2026-03
Corcept Therapeutics USD 12.89M 22K 2026-03
Drreddys Laboratories INR 76.53B 2.48B 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.16B 39M 2026-03
J&J USD 14.58B 392M 2026-03
Merck USD 6.48B 179M 2026-03
Novartis USD 6.29B 17M 2026-03
Novartis USD 6.29B 135M 2026-03
Pacira USD 150.37M 2.49M 2026-03
Perrigo USD 1.12B 27.6M 2026-03
Pfizer USD 10.67B 13M 2026-03
Phibro Animal Health USD 539.7M 22.35M 2026-03
Prestige Brands USD 159.13M 4.46M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sanofi EUR 23.5B 812M 2026-03
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
Zoetis USD 2.55B 120M 2026-03